- Home
- RFMZ vs CYRX Comparison
RFMZ vs CYRX Comparison
Compare RFMZ & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFMZ
- CYRX
- Stock Information
- Founded
- RFMZ 2021
- CYRX 1999
- Country
- RFMZ United States
- CYRX United States
- Employees
- RFMZ N/A
- CYRX N/A
- Industry
- RFMZ Trusts Except Educational Religious and Charitable
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- RFMZ Finance
- CYRX Health Care
- Exchange
- RFMZ Nasdaq
- CYRX Nasdaq
- Market Cap
- RFMZ 300.5M
- CYRX 310.4M
- IPO Year
- RFMZ N/A
- CYRX N/A
- Fundamental
- Price
- RFMZ $12.27
- CYRX $5.52
- Analyst Decision
- RFMZ
- CYRX Strong Buy
- Analyst Count
- RFMZ 0
- CYRX 7
- Target Price
- RFMZ N/A
- CYRX $11.29
- AVG Volume (30 Days)
- RFMZ 76.6K
- CYRX 552.3K
- Earning Date
- RFMZ 01-01-0001
- CYRX 05-06-2025
- Dividend Yield
- RFMZ 7.43%
- CYRX N/A
- EPS Growth
- RFMZ N/A
- CYRX N/A
- EPS
- RFMZ 0.65
- CYRX N/A
- Revenue
- RFMZ N/A
- CYRX $228,385,000.00
- Revenue This Year
- RFMZ N/A
- CYRX N/A
- Revenue Next Year
- RFMZ N/A
- CYRX $5.30
- P/E Ratio
- RFMZ $21.49
- CYRX N/A
- Revenue Growth
- RFMZ N/A
- CYRX N/A
- 52 Week Low
- RFMZ $11.28
- CYRX $4.58
- 52 Week High
- RFMZ $14.57
- CYRX $17.41
- Technical
- Relative Strength Index (RSI)
- RFMZ 23.40
- CYRX 45.65
- Support Level
- RFMZ $12.25
- CYRX $5.34
- Resistance Level
- RFMZ $12.62
- CYRX $5.97
- Average True Range (ATR)
- RFMZ 0.30
- CYRX 0.61
- MACD
- RFMZ -0.04
- CYRX 0.02
- Stochastic Oscillator
- RFMZ 28.24
- CYRX 50.28
About RFMZ RiverNorth Flexible Municipal Income Fund II Inc.
RiverNorth Flex Muni Income Fund II Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.